Tango Therapeutics grants new hire 170,000-share stock option at $23.1, awards 40,000 RSUs

Tango Therapeutics, Inc.

Tango Therapeutics, Inc.

TNGX

0.00
  • Tango Therapeutics granted equity inducement awards effective June 1, 2026, to a new employee under its 2023 Inducement Plan.
  • Award includes a non-qualified stock option for 170,000 shares at an exercise price of $23.1 per share.
  • Grant also includes 40,000 restricted stock units, vesting in three equal annual installments.
  • Options vest 25% on the first anniversary of the start date, then monthly over 36 months, subject to continued employment.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tango Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606050700PRIMZONEFULLFEED9732312) on June 05, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.